• Lose body fat
  • Increase energy levels
  • Preserve lean muscle
  • Improve metabolism

CLA (conjugated linoleic acid) is a beneficial unsaturated fatty acid naturally present in dairy and meat products. Created in the stomachs of ruminant animals such as cows, one of the most potent natural sources of CLA is beef, with grass-fed livestock producing more than their corn-fed counterparts.1

Clinical research has shown that CLA is associated with loss of body fat.2,3,4 Doses of between 1.8 and 3 grams per day have been shown to reduce body fat in human studies, while preserving lean muscle mass.5 Supplementing with CLA as part of a healthy exercise and nutrition program may increase metabolism and aids fat burning potential, helping to maintain a healthy body weight over the long term. This fatty acid supports lean body mass and healthy adults can benefit from its ability to help regulate cellular energy intake and output, reducing fat composition particularly in the abdominal area.6,7

Other Ingredients:
Safflower seed oil, gelatin, glycerin, purified water, caramel color and titanium dioxide.
Do not exceed recommended dose. This product is not intended for pregnant or nursing mothers, children under the age of 18, or persons with a known medical condition. If you have questions about the advisability of taking this product, consult your physician prior to use. This product is manufactured and packaged in a facility which may also process milk, soy, wheat, egg, peanuts, tree nuts, sh and crustacean shellsh.
As a dietary supplement, take one (1) to two (2) capsules with breakfast and one (1) to two (2) capsules with dinner.

TRANSCEND‘s CLA 1000 mg contains 120 softgels per bottle.

  1. Dhiman TR, Anand GR, Satter LD, Pariza MW. Conjugated linoleic acid content of milk from cows fed different diets. J Dairy Sci 1999 Oct;82(10):2146-56.
  2. Thom E, Wadstein J, Gudmundsen O. (Sep-Oct 2001). "Conjugated linoleic acid reduces body fat in healthy exercising humans". The Journal of International Medical Research 29 (5): 392-396.
  3. Gaullier JM, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. "Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans." Am J Clin Nutr. 2004 Jun;79(6):1118-25.
  4. Hargrave-Barnes KM, Azain MJ, Miner JL."Conjugated linoleic acid-induced fat loss dependence on Delta6-desaturase or cyclooxygenase." Obesity (Silver Spring). 2008 Oct;16(10):2245-52.
  5. Whigham LD, Watras AC, and Schoeller DA. "Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans." Am. J. Clinical Nutrition. May 2007; 85(5): 1203-11.
  6. Li JJ, Huang CJ, Xie D."Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid." Mol Nutr Food Res. 2008 Jun;52(6):631-45.
  7. Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O."Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese." Br J Nutr. 2007 Mar;97(3):550-60.
  8. A C Watras, A C Buchholz, R N Close, Z Zhang and D A Schoeller. "The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain." Int J Obes. 2007; 31:481-487.
  9. J Nutr. 2002 Oct;132(10):2995-8. "Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action." Belury MA.
  10. Carcinogenesis. 1999 Jun;20(6):1019-24. "Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid." Banni S, Angioni E, Casu V, Melis MP, Carta G, Corongiu FP, Thompson H, Ip C.
  11. Tarling EJ, Ryan KJ, Bennett AJ, Salter AM."Effect of dietary conjugated linoleic acid isomers on lipid metabolism in hamsters fed high-carbohydrate and high-fat diets."Br J Nutr. 2008 Nov 5:1-9.
  12. Nicolosi RJ, Rogers EJ, Kritchevsky D, Scimeca JA, Huth PJ. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 1997;22(5):266-77.

You recently viewed

Clear recently viewed